Dew,
Have you ever thought of starting a Biotech Short Fund?
Ticker name: DDBS (Dew's Biotech Short Fund).
It could be made up primarily of shorted prostate cancer cure stocks.
Surely, out of the 280 prostate cancer stocks that exist (from your message #5738), and we all know that few of them will ever be approved. So, how can we go wrong investing in it?
I'd like to hedge my long Dendreon position, so I'll be the first to buy into DDBS.
You'd make a fortune on the fees, and that ure beats moderating a board for a stock you don't believe will work.
DownTheStretch
